Stacey Richardson

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Therapy and biomarker dependent progression-free survival in infant sonic hedgehog medulloblastoma: a multi-national retrospective cohort study.

Therapy and biomarker dependent progression-free survival in infant sonic hedgehog medulloblastoma: a multi-national retrospective cohort study.

Journal: EClinicalMedicine

Published: December 22, 2025

Integrated biomarker and treatment correlates of prognosis in infant non-WNT/non-SHH medulloblastoma: a multinational retrospective cohort study.

Integrated biomarker and treatment correlates of prognosis in infant non-WNT/non-SHH medulloblastoma: a multinational retrospective cohort study.

Journal: The Lancet. Child & adolescent health

Published: October 31, 2025

MIF-CD74 signaling drives immune modulation in medulloblastoma.

MIF-CD74 signaling drives immune modulation in medulloblastoma.

Journal: Neuro-oncology

Published: June 13, 2025

MIF-CD74 signaling drives immune modulation in medulloblastoma.

MIF-CD74 signaling drives immune modulation in medulloblastoma.

Journal: Neuro-oncology

Published: June 13, 2025

Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.

Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.

Journal: Acta neuropathologica

Published: January 18, 2023

Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.

Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.

Journal: Cancer research

Published: June 28, 2022

ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors.

ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors.

Journal: Nature communications

Published: March 25, 2022

Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation.

Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation.

Journal: Cell death and differentiation

Published: August 10, 2021

Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development.

Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development.

Journal: Cell reports

Published: July 26, 2021

Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse.

Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse.

Journal: Neuro-oncology

Published: July 17, 2021

Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study.

Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study.

Journal: The Lancet. Child & adolescent health

Published: May 11, 2020

EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.

EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.

Journal: Blood

Published: September 14, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026